Clinicopathologic Findings in High-Grade B-Cell Lymphomas With Typical Burkitt Morphologic Features but Lacking theMYCTranslocation
Author(s) -
Deborah W. Sevilla,
Jerald Z. Gong,
Barbara K. Goodman,
Patrick J. Buckley,
Philip M. Rosoff,
Jon P. Gockerman,
Anand S. Lagoo
Publication year - 2007
Publication title -
american journal of clinical pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.859
H-Index - 128
eISSN - 1943-7722
pISSN - 0002-9173
DOI - 10.1309/c1pp15p7cdb8uy39
Subject(s) - immunophenotyping , lymphoma , burkitt's lymphoma , chromosomal translocation , cd20 , pathology , cd43 , chemotherapy , b cell , gene rearrangement , cancer research , biology , medicine , antibody , immunology , flow cytometry , gene , biochemistry
In the World Health Organization classification, cases with classical Burkitt morphologic features and a very high proliferation fraction but without the MYC translocation are not clearly designated as a separate entity and are usually categorized as diffuse large B-cell lymphoma (DLBCL). We identified from our records 33 cases of highly aggressive mature B-cell neoplasms from 8 children and 25 adults with typical Burkitt cytomorphologic, histologic, and immunophenotypic (CD20+/CD10+ and surface immunoglobulin-positive) features. Rearrangement of MYC (MYC+) was present in only 18 of 33 cases, but the proliferation fraction was more than 90% in all MYC-cases (no MYC rearrangement). The immunophenotype of the lymphoma cells in the 2 groups was similar. Although children with MYC+ and MYC- neoplasms were treated with chemotherapy regimens appropriate for Burkitt lymphoma, adults with MYC- lymphomas received less aggressive therapy usually given for DLBCL. Survival analysis showed that adults in the MYC- group had an inferior outcome compared with adults with MYC+ disease. Provisional identification of MYC- lymphomas with typical Burkitt morphologic features as an entity separate from DLBCL will facilitate further studies and possible categorization as a separate entity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom